Filing Details
- Accession Number:
- 0001209191-15-005931
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-22 18:33:06
- Reporting Period:
- 2015-01-20
- Filing Date:
- 2015-01-22
- Accepted Time:
- 2015-01-22 18:33:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1310880 | David Hung | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-01-20 | 20,866 | $107.57 | 944,192 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-20 | 64,234 | $108.09 | 879,958 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-20 | 14,900 | $109.17 | 865,058 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 86,060 | Indirect | By Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $106.82 to $107.81. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regading the number of shares sold at each separate price.
- The shares were sold at prices ranging from $107.82 to $108.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regading the number of shares sold at each separate price.
- The shares were sold at prices ranging from $108.83 to $109.54. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regading the number of shares sold at each separate price.